Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
60 /100
HIGH RISK
Score updated Aug 28, 2026

SNSE — Sensei Biotherapeutics, Inc. Dilution Risk Tracker

Track SNSE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SNSE — Get alerts when the score changes →

As of August 28, 2026, Sensei Biotherapeutics, Inc. (SNSE) has a DilutionWatch DilutionScore of 60/100, rated HIGH dilution risk. Sensei Biotherapeutics, Inc. has a market capitalization of $28.37M, 25.84M shares outstanding. Stored dilution-related fields include shelf registration capacity of $200.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
0
📊 Float Risk
100
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

Watch
Minor dilution signals detected
model est. 13%
💰 Capital Raise model 20%
• Active shelf registration ($200M, 705% of market cap)
📉 Score Deterioration model 10%
• Score in HIGH risk zone (60/100)
🔔 Track SNSE — Get forecast alerts →

Market Data

Market Cap$28.37M
Shares Outstanding25.84M
Float811.9K
Cash$167.37M
Debt$567.0K
Short InterestN/A

Institutional Holdings

1.5% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track SNSE for full holder detail →

Short Interest

No current FINRA short-interest record is available for this ticker.

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-31
xbrl XBRL CONVERTIBLE 2021-12-31
S-3 SHELF 2026-04-28
8-K 8K EVENT 2026-04-16
4 INSIDER TRANSACTION 2026-04-14
Full SEC filing analysis available with free account

Recent News

No recent news

Factual SNSE Dilution Snapshot

Sensei Biotherapeutics, Inc. (SNSE) has a DilutionScore of 60/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track SNSE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SNSE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for SNSE
SNSE FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.